Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies

. 1989 ; 91 (3) : 235-44.

Jazyk angličtina Země Německo Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid02722565

An immunohistochemical study of the expression of the secretory component (SC) in human mammary gland epithelium at various stages of differentiation, as well as in benign and malignant breast tumours, was undertaken using three mouse monoclonal antibodies. Antibody RICEO-SC-05 (SC-05), raised against a partially purified preparation of human SC, and reacting with a reduction-resistant epitope present in both free and polymeric immunoglobulin-bound SC, was compared in immunoperoxidase and immunofluorescence studies on a diverse range of normal tissues, to 2 reference anti-SC antibodies (LICR-LONLC28 and RICEO-MFG-12). All three antibodies reacted with secretory epithelia only, consistent with known patterns of expression of SC in tissues, although there was an unexpected reaction by all anti-SC antibodies with some Hassal's corpuscles of the thymus. Staining patterns seen in the normal resting, pregnant, lactating and regressing (after weaning) breast provide evidence for differentiation-associated changes in the production of SC, and support the concept of terminal ductal lobular units (TDLUs) as functional compartments of the mammary gland. SC was detected in all but one benign breast lesion (n = 53) as compared to only 24% positive cases with heterogeneous expression of SC found among 176 primary and metastatic breast carcinomas examined. In a series of 40 primary breast carcinomas and their corresponding lymph node metastases, a good overall correlation was found between the expression of SC in the matched specimens; aside from 3 heterogeneously SC-positive carcinomas whose metastatic counterparts were SC-negative. Our results demonstrate a potential application for monoclonal antibodies to SC in the study of human mammary gland differentiation, but suggest that the value of an assay for SC in the diagnosis of breast carcinomas is questionable due to the generally low expression of SC by either primary or metastatic breast lesions.

Zobrazit více v PubMed

Int J Cancer. 1988 Oct 15;42(4):638-41 PubMed

J Cell Sci. 1985 Apr;75:17-33 PubMed

Int J Cancer. 1985 Sep 15;36(3):299-306 PubMed

Virchows Arch A Pathol Anat Histol. 1982;397(3):327-33 PubMed

Br J Cancer. 1987 Dec;56(6):727-33 PubMed

Immunology. 1984 Nov;53(3):427-33 PubMed

J Immunol. 1984 Oct;133(4):2116-25 PubMed

J Immunol Methods. 1983 Sep 16;62(3):325-9 PubMed

Am J Pathol. 1981 Oct;105(1):47-53 PubMed

Eur J Cancer Clin Oncol. 1986 Dec;22(12):1441-52 PubMed

J Clin Pathol. 1987 Jun;40(6):621-5 PubMed

Scand J Immunol. 1985 Aug;22(2):111-46 PubMed

Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;79(2):165-88 PubMed

Eur J Immunol. 1984 Apr;14(4):344-9 PubMed

Am J Obstet Gynecol. 1979 Aug 15;134(8):899-903 PubMed

J Pathol. 1981 Sep;135(1):87-95 PubMed

Proc Natl Acad Sci U S A. 1980 Dec;77(12):7257-61 PubMed

Nature. 1984 Sep 6-11;311(5981):71-3 PubMed

Ann N Y Acad Sci. 1985;455:649-68 PubMed

Ann N Y Acad Sci. 1985;455:282-306 PubMed

Int J Cancer. 1987 Sep 15;40(3):319-27 PubMed

Histochem J. 1986 Oct;18(10):565-75 PubMed

J Biol Chem. 1982 Aug 25;257(16):9612-21 PubMed

Scand J Immunol. 1974;3(5):579-88 PubMed

Am J Clin Pathol. 1984 Dec;82(6):660-5 PubMed

Immunol Lett. 1982 May;4(5):231-5 PubMed

Eur J Cancer Clin Oncol. 1987 Oct;23(10):1557-63 PubMed

Nature. 1985 Mar 7-13;314(6006):53-7 PubMed

Ann N Y Acad Sci. 1983 Jun 30;409:353-82 PubMed

Gastroenterology. 1985 Sep;89(3):667-82 PubMed

J Biol Chem. 1979 Nov 10;254(21):11072-81 PubMed

Cancer Immunol Immunother. 1985;19(3):226-30 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace